Your browser doesn't support javascript.
loading
TRAF6 directs FOXP3 localization and facilitates regulatory T-cell function through K63-linked ubiquitination.
Ni, Xuhao; Kou, Wei; Gu, Jian; Wei, Ping; Wu, Xiao; Peng, Hao; Tao, Jinhui; Yan, Wei; Yang, Xiaoping; Lebid, Andriana; Park, Benjamin V; Chen, Zuojia; Tian, Yizhu; Fu, Juan; Newman, Stephanie; Wang, Xiaoming; Shen, Hongbin; Li, Bin; Blazar, Bruce R; Wang, Xuehao; Barbi, Joseph; Pan, Fan; Lu, Ling.
Afiliação
  • Ni X; Translational Medicine Research Center of Affiliated Jiangning Hospital, Liver Transplantation Center of First Affiliated Hospital, and Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Kou W; Immunology and Hematopoiesis Division, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Gu J; Department of Otolaryngology, Pediatric Research Institute The Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Wei P; Translational Medicine Research Center of Affiliated Jiangning Hospital, Liver Transplantation Center of First Affiliated Hospital, and Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Wu X; Immunology and Hematopoiesis Division, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Peng H; Department of Otolaryngology, Pediatric Research Institute The Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Tao J; Translational Medicine Research Center of Affiliated Jiangning Hospital, Liver Transplantation Center of First Affiliated Hospital, and Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Yan W; Translational Medicine Research Center of Affiliated Jiangning Hospital, Liver Transplantation Center of First Affiliated Hospital, and Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Yang X; Immunology and Hematopoiesis Division, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Lebid A; Translational Medicine Research Center of Affiliated Jiangning Hospital, Liver Transplantation Center of First Affiliated Hospital, and Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Park BV; Immunology and Hematopoiesis Division, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Chen Z; Immunology and Hematopoiesis Division, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Tian Y; Immunology and Hematopoiesis Division, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Fu J; Shanghai Institute of Immunology, Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Newman S; Translational Medicine Research Center of Affiliated Jiangning Hospital, Liver Transplantation Center of First Affiliated Hospital, and Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Wang X; Immunology and Hematopoiesis Division, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Shen H; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Li B; State Key Laboratory of Reproductive Medicine, Department of Immunology, Nanjing Medical University, Nanjing, China.
  • Blazar BR; Department of Epidemiology and Biostatistics, School of Public Health, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Wang X; Shanghai Institute of Immunology, Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Barbi J; Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
  • Pan F; Translational Medicine Research Center of Affiliated Jiangning Hospital, Liver Transplantation Center of First Affiliated Hospital, and Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Lu L; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
EMBO J ; 38(9)2019 05 02.
Article em En | MEDLINE | ID: mdl-30886050
ABSTRACT
Regulatory T cells (Tregs) are crucial mediators of immune control. The characteristic gene expression and suppressive functions of Tregs depend considerably on the stable expression and activity of the transcription factor FOXP3. Transcriptional regulation of the Foxp3 gene has been studied in depth, but both the expression and function of this factor are also modulated at the protein level. However, the molecular players involved in posttranslational FOXP3 regulation are just beginning to be elucidated. Here, we found that TRAF6-deficient Tregs were dysfunctional in vivo; mice with Treg-restricted deletion of TRAF6 were resistant to implanted tumors and displayed enhanced anti-tumor immunity. We further determined that FOXP3 undergoes K63-linked ubiquitination at lysine 262 mediated by the E3 ligase TRAF6. In the absence of TRAF6 activity or upon mutation of the ubiquitination site, FOXP3 displayed aberrant, perinuclear accumulation and disrupted regulatory function. Thus, K63-linked ubiquitination by TRAF6 ensures proper localization of FOXP3 and facilitates the transcription factor's gene-regulating activity in Tregs. These results implicate TRAF6 as a key posttranslational, Treg-stabilizing regulator that may be targeted in novel tolerance-breaking therapies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Linfócitos T Reguladores / Colite / Fator 6 Associado a Receptor de TNF / Fatores de Transcrição Forkhead / Ubiquitinação / Lisina Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: EMBO J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Linfócitos T Reguladores / Colite / Fator 6 Associado a Receptor de TNF / Fatores de Transcrição Forkhead / Ubiquitinação / Lisina Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: EMBO J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China